Related Experiment Video
Updated: May 20, 2026

Quantification of Acanthamoeba spp. Motility
Published on: September 20, 2024
Cyanoacrylamide derivatives as a novel amoebicidal agents against Acanthamoeba spp
Rubén L Rodríguez-Expósito1, Samuel Delgado-Hernández2, Ines Sifaoui1
1Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203 La Laguna, Tenerife, Islas Canarias, Spain; Departamento de Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna, Tenerife, Islas Canarias, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid 28029, Spain.
Abstract:
Acanthamoeba spp. are ubiquitous protozoa and the causative agents of severe human infections, including granulomatous amoebic encephalitis (GAE) and Acanthamoeba keratitis (AK). The lack of standardised and fully effective treatments highlights the urgent need for novel therapeutic agents. In this study, we evaluated the in vitro amoebicidal activity of 8 cyanoacrylamide derivatives (QOET) against three different strains of Acanthamoeba: A. castellanii Neff, A. griffini and A. polyphaga. Among the tested compounds, QOET-112 and 114 displayed the lowest IC50 values against both the trophozoite and cyst stages compared to the other derivatives. Furthermore, these compounds demonstrated low cytotoxicity against the murine macrophage cell line J774A.1. Analysis of the mode of action evidenced that both cyanoacrylamides triggered programmed cell death (PCD) and autophagy in A. griffini trophozoites. Additionally, these compounds induced severe cytoskeletal alterations, specifically characterised by the disorganisation and disruption of the actin and tubulin networks.
Insights
Novel cyanoacrylamide derivatives show promise as amoebicidal agents against Acanthamoeba, a cause of severe human infections like keratitis. Compounds QOET-112 and 114 exhibit potent activity and low cytotoxicity, warranting further investigation.
Area of Science:
- Microbiology
- Parasitology
- Drug Discovery
Background:
- Acanthamoeba spp. cause severe human infections, including granulomatous amoebic encephalitis (GAE) and Acanthamoeba keratitis (AK).
- Current treatments for Acanthamoeba infections are limited and often ineffective, necessitating the development of new therapeutic strategies.
- The urgent need for novel amoebicidal agents is driven by the severity and prevalence of these protozoan infections.
Purpose of the Study:
- To evaluate the in vitro amoebicidal activity of eight cyanoacrylamide derivatives (QOET) against Acanthamoeba.
- To identify specific compounds with potent activity against both trophozoite and cyst stages of Acanthamoeba.
- To investigate the mechanism of action and cytotoxicity of promising cyanoacrylamide derivatives.
Main Methods:
- In vitro screening of eight cyanoacrylamide derivatives against three Acanthamoeba strains (A. castellanii, A. griffini, A. polyphaga).
- Determination of IC50 values for trophozoite and cyst stages.
- Cytotoxicity assessment using the murine macrophage cell line J774A.1.
- Analysis of the mode of action, including programmed cell death (PCD), autophagy, and cytoskeletal alterations (actin and tubulin networks).
Main Results:
- Two compounds, QOET-112 and QOET-114, exhibited the lowest IC50 values against both trophozoite and cyst stages of Acanthamoeba.
- These effective compounds demonstrated low cytotoxicity against the J774A.1 macrophage cell line.
- Mechanism of action studies revealed that QOET-112 and QOET-114 induce programmed cell death (PCD) and autophagy in A. griffini trophozoites.
- Significant cytoskeletal disorganization, including actin and tubulin network disruption, was observed.
Conclusions:
- Cyanoacrylamide derivatives, particularly QOET-112 and QOET-114, possess significant in vitro amoebicidal activity against Acanthamoeba.
- These compounds represent potential candidates for developing new treatments against Acanthamoeba infections due to their efficacy and low cytotoxicity.
- The observed induction of PCD, autophagy, and cytoskeletal disruption provides insights into the anti-Acanthamoeba mechanism of these novel agents.
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
Amines to Amides: Acylation of Amines
Next, the second equivalent of amine serves as a Brønsted base and deprotonates the quaternary amide...
Inhibitors of Bacterial Protein Synthesis
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Physical Properties of Amines

